1. Takahashi H, Iwahashi N, Kirigaya J, et al. Glycemic variability
determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome. Cardiovasc Diabetol
17: 116, 2018.
2. Yamamoto H, Shinke T, Otake H, et al. Impact of daily glucose
fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease
undergoing lipid-lowering therapy. J Diabetes Investig 12: 10151024, 2021.
3. Kumagai R, Muramatsu A, Fujii M, et al. Comparison of glucose
monitoring between Freestyle Libre Pro and iPro2 in patients with
diabetes mellitus. J Diabetes Investig 10: 851-856, 2019.
4. Kuroda M, Shinke T, Sakaguchi K, et al. Effect of daily glucose
fluctuation on coronary plaque vulnerability in patients pre-treated
with lipid-lowering therapy: a prospective observational study.
JACC Cardiovasc Interv 8: 800-811, 2015.
5. Gohbara M, Hibi K, Mitsuhashi T, et al. Glycemic variability on
continuous glucose monitoring system correlates with non-culprit
vessel coronary plaque vulnerability in patients with first-episode
acute coronary syndrome - optical coherence tomography study.
Circ J 80: 202-210, 2016.
6. Kitani S, Igarashi Y, Tsuchikane E, et al. Efficacy of drug-coated
balloon angioplasty after directional coronary atherectomy for
coronary bifurcation lesions (DCA/DCB registry). Catheter Cardiovasc Interv 97: E614-E623, 2021.
7. Vos NS, Fagel ND, Amoroso G, et al. Paclitaxel-coated balloon
angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial. JACC Cardiovasc Interv
12: 1691-1699, 2019.
8. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on
acute coronary syndromes: the pathologists’ view. Eur Heart J 34:
719-728, 2013.
9. Matsumura M, Mintz GS, Kang SJ, et al. Intravascular ultrasound
and near-infrared spectroscopic features of coronary lesions with
12.
13.
14.
15.
16.
17.
18.
intraplaque haemorrhage. Eur Heart J Cardiovasc Imaging 18:
1222-1228, 2017.
Kubota T, Shoda K, Ushigome E, et al. Utility of continuous glucose monitoring following gastrectomy. Gastric Cancer 23: 699706, 2020.
Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233-240, 1999.
International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology,
pathogenesis, and management. Lancet Diabetes Endocrinol 7:
385-396, 2019.
Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention
of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
Lancet 359: 2072-2077.
Yamamoto H, Konishi A, Shinke T, et al. The impact of
vildagliptin on the daily glucose profile and coronary plaque stability in impaired glucose tolerance patients with coronary artery
disease: VOGUE-A multicenter randomized controlled trial. BMC
Cardiovasc Disord 21: 92, 2021.
Catan A, Turpin C, Diotel N, et al. Aging and glycation promote
erythrocyte phagocytosis by human endothelial cells: potential impact in atherothrombosis under diabetic conditions. Atherosclerosis
291: 87-98, 2019.
Costa PZ, Soares R. Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci 92: 10371045, 2013.
Chen Y, Waqar AB, Nishijima K, et al. Macrophage-derived
MMP-9 enhances the progression of atherosclerotic lesions and
vascular calcification in transgenic rabbits. J Cell Mol Med 24:
4261-4274, 2020.
Risso A, Mercuri F, Quagliaro L, Damante G, Ceriello A. Intermittent high glucose enhances apoptosis in human umbilical vein
endothelial cells in culture. Am J Physiol Endocrinol Metab 281:
E924-E930, 2001.
The Internal Medicine is an Open Access journal distributed under the Creative
Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To
view the details of this license, please visit (https://creativecommons.org/licenses/
by-nc-nd/4.0/).
Ⓒ 2023 The Japanese Society of Internal Medicine
Intern Med 62: 399-403, 2023
403
...